Episode 07: Australia, New Zealand a commercial lens

 
 
Presentations are tools that can be demonstrations, lectures, speeches, and more. (11).png

Join an esteemed panel of industry leaders as they discuss key commercial insights about the Australian and New Zealand cannabis markets.

The panel will cover import/export in Australia and New Zealand, distribution across these markets, patient access figures and how these markets are developing.

Speakers

Warren Everitt - Chief Executive Officer, MediPharm Labs Asia Pacific

Warren brings a wealth of senior leadership to MediPharm Labs Australia, having run both his own small businesses as well as achieved success in the Asia Pacific for a leading international digital marketing agency. Warren completed an Honours Bachelor Computer Science (programming) and was on the leading edge of web development and digital marketing, working first in Canada and the UK before building the Asia Pacific division of a large enterprise marketing agency, MarketOne. Over 8 years, Warren opened four offices, adding 200+ staff in Melbourne, Singapore, Bangalore and Tokyo. He boasts a 15-year history in sales and marketing, consulting to some of the biggest companies in the world.

Mark Lucas – Executive Director and Chief Executive Officer, CannaSouth

Mark is an experienced business manager who designs and implements operational business systems throughout Cannasouth. With strong data system DNA, Mark is a skilled manager who brings a wealth of business knowledge and experience to this role. Mark’s business background spans 25 years. He is an entrepreneur by nature with a passion for business and has been involved in a number of businesses from initial conception through to mature, well-established companies. Mark’s key strengths include management, human resources/staff, project management, contract negotiation, sales and marketing, financial control, and business strategy.

Paul Manning - Chief Executive Officer, Helius Therapeutics

In 2017, Paul Manning co-founded biotechnology firm, Helius Therapeutics, focused on researching, developing and commercialising medicinal cannabis. In 2018 we raise $15m in our Series A & B capital rounds and in 2020 we raised a further $20m, taking our market cap to $105m. Today, Helius is New Zealand's largest licensed medicinal cannabis company.

Guy Headley - Co Founder, Commercial Director at CDA Health

Guy Headley is the commercial director at CDA. CDA Health is the parent company of Cannabis Doctors Australia whom run patient access Medical Cannabis Clinics Australia-wide having conducted over 10,000 patient consultations. Burleigh Heads Cannabis, licensed Cannabis import/export distribution facility. Canview, Australia's go to online Cannabis Marketplace bridging the gap between pharmacists, prescribes and brands. Canview currently stocks the widest range of products available in Australia with over 60 available products.